GlassScriptPhysician profile
Dustin E Hawley
NPI 1831416015
$1,042.92
in general payments reported to CMS, 2019-2025
23 companies · $298 in 2025
The $298 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $138 · 2020: $86.61 · 2021: $104 · 2022: $112 · 2023: $162 · 2024: $144 · 2025: $298.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $603.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $603.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $206.41 | 2021-2025 | |
| Lilly USA, LLC | $127.07 | 2019-2025 | Zepbound, Mounjaro, Jardiance |
| Sanofi-Aventis U.S. LLC | $76.09 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $73.80 | 2024-2025 | Farxiga, Breztri |
| Glaxosmithkline, LLC. | $70.29 | 2020-2023 | Trelegy Ellipta |
| Boehringer Ingelheim Pharmaceuticals, INC. | $65.49 | 2020-2022 | |
| Pfizer INC. | $54.49 | 2019-2021 | |
| Inspire Medical Systems, INC. | $45.86 | 2024 | Inspire |
| Takeda Pharmaceuticals U.S.A., INC. | $39.89 | 2019-2023 | Trintellix |
| Tactile Systems Technology INC | $37.20 | 2023 | Flexitouch Plus, Entre Plus |
| Phathom Pharmaceuticals, INC. | $35.37 | 2025 | Voquezna |
| Biohaven Pharmaceutical Holding Company LTD. | $28.68 | 2022 | |
| Astellas Pharma US INC | $23.75 | 2025 | Veozah |
| Lundbeck LLC | $20.92 | 2025 | Vyepti |
| Cook Medical LLC | $19.90 | 2020 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axsome Therapeutics, INC. | $17.01 | 2023 | Auvelity |
| Bayer Healthcare Pharmaceuticals INC. | $15.86 | 2025 | |
| Genentech USA, INC. | $15.85 | 2021 | |
| Janssen Pharmaceuticals, INC | $15.00 | 2020 | |
| Novo Nordisk INC | $14.62 | 2023 | Ozempic |
| Exact Sciences Corporation | $13.97 | 2025 | Cologuard Collection Kit |
| Hologic Sales and Service, LLC | $13.53 | 2020 | |
| Allergan, INC. | $11.87 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dustin Hawley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.